Friederike Jönsson Selected Research

IgG Receptors (Fc gamma RI)

1/2018	Platelets expressing IgG receptor FcγRIIA/CD32A determine the severity of experimental anaphylaxis.
4/2017	Mechanisms of anaphylaxis in human low-affinity IgG receptor locus knock-in mice.
2/2013	The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy.
3/2012	Human FcγRIIA induces anaphylactic and allergic reactions.
4/2011	Mouse and human neutrophils induce anaphylaxis.
2/2011	Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Friederike Jönsson Research Topics

Disease

9	Anaphylaxis (Anaphylactic Shock) 01/2021 - 04/2011
5	Inflammation (Inflammations) 06/2017 - 02/2013
3	Hypersensitivity (Allergy) 10/2019 - 01/2012
3	Arthritis (Polyarthritis) 06/2017 - 02/2011
2	Neoplasms (Cancer) 10/2013 - 02/2013
2	Melanoma (Melanoma, Malignant) 10/2013 - 02/2013
1	Infections 01/2022
1	Cytopenia 01/2022
1	Transfusion-Related Acute Lung Injury 12/2021
1	Edema (Dropsy) 12/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2017
1	Endotoxemia 01/2017
1	Mastocytoma 12/2016
1	Ulcer 05/2015
1	Wiskott-Aldrich Syndrome 05/2015
1	Rheumatoid Arthritis 09/2014
1	Nemaline Myopathies (Nemaline Myopathy) 05/2014
1	Muscular Diseases (Myopathy) 05/2014
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Neutropenia 09/2012
1	Immediate Hypersensitivity 01/2012
1	Atopic Dermatitis (Atopic Eczema) 02/2009

Drug/Important Bio-Agent (IBA)

13	Immunoglobulin G (IgG)IBA 01/2022 - 02/2011
6	AntibodiesIBA 01/2022 - 04/2011
6	IgG Receptors (Fc gamma RI)IBA 01/2018 - 02/2011
4	Immunoglobulin E (IgE)IBA 10/2019 - 01/2012
3	AutoantibodiesIBA 01/2022 - 02/2011
3	AntigensIBA 01/2022 - 12/2016
3	AllergensIBA 10/2019 - 12/2016
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 09/2012
2	Immunoglobulin IsotypesIBA 01/2022 - 10/2019
2	Monoclonal AntibodiesIBA 12/2021 - 10/2013
2	Serotonin (5 Hydroxytryptamine)IBA 12/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 10/2019 - 01/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 04/2017 - 09/2014
2	Fc Receptors (Fc Receptor)IBA 01/2017 - 09/2014
2	IgE Receptors (Fc epsilon RI)IBA 03/2012 - 01/2012
1	Serotonin ReceptorsIBA 12/2021
1	sarpogrelateIBA 12/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	Neuromuscular Blocking AgentsIBA 10/2019
1	Histamine Receptors (Histamine Receptor)IBA 04/2017
1	platelet activating factor receptorIBA 04/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	EnzymesIBA 01/2017
1	Diphtheria ToxinIBA 01/2017
1	EndotoxinsIBA 01/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Growth Factor ReceptorsIBA 12/2016
1	Angiotensin IIIBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	mycolactoneIBA 05/2015
1	Tyrosine (L-Tyrosine)FDA Link 09/2014
1	hippuryl-glycyl-glycine (HIGG)IBA 09/2014
1	Protein AggregatesIBA 05/2014
1	Destrin (Actin Depolymerizing Factor)IBA 05/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2012
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 09/2012
1	anti-IgE antibodiesIBA 02/2009

Therapy/Procedure

3	Immunotherapy 06/2017 - 02/2013
2	Therapeutics 10/2013 - 04/2011
1	General Anesthesia 10/2019
1	Analgesia 05/2015